Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Barton McCombie Deoxygenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104945363B reveals a scalable synthesis for SGLT2 inhibitor intermediates, offering cost-effective alternatives to conventional dapagliflozin-based routes for pharmaceutical supply chains.
Patent CN102010455B reveals a novel Decitabine synthesis avoiding isomer separation. High purity >99.85% via Barton-McCombie deoxygenation for cost-effective manufacturing.